ABT vs SYK
ABT and SYK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABTABBOTT LABORATORIES | SYKSTRYKER CORP |
|---|---|---|
| Market cap | $175.37B | $122.58B |
| P/E (TTM) | 28.2 | 37.0 |
| P/B | 3.37 | 10.45 |
| P/S | 4.0x | 4.9x |
| Dividend yield | 2.35% | — |
| Revenue | $45.13B(TTM) | $25.27B(TTM) |
| Revenue growth (YoY) | 5.7% | 11.2% |
| Net income | $6.28B(TTM) | $3.34B(TTM) |
| Earnings growth (YoY) | -51.3% | 8.5% |
| EPS, diluted | $3.57(TTM) | $8.64(TTM) |
| EBIT margin | 18.2% | 19.5% |
| ROE | 12.5% | 27.7% |
| ROIC | 8.3% | 14.9% |
| Piotroski F | — | 8/9 |
| 1y total return | -14.5% | -17.0% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ABT frente a SYK
| Métrica | ABT | SYK |
|---|---|---|
| Valor final | $30.8K | $34.2K |
| Retorno total | +208.4% | +242.3% |
| CAGR | +11.5% | +12.6% |
| Volatilidad | 23.9% | 26.3% |
| Sharpe | 0.42 | 0.44 |
| Sortino | 0.59 | 0.63 |
| Caída máxima | -39.6% | -43.8% |
Basado en 2600 días de negociación comunes, 2016-03-15 → 2026-07-17 · tasa libre de riesgo 3.85% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)